• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
FCA Recoveries Decline despite Increase in Enforcement Activity

FCA Recoveries Decline despite Increase in Enforcement Activity

by Glenn S. Demby | Apr 19, 2023 | News, Open Content

The DOJ’s 2022 Fraud Statistics Overview shows it raked in less than 50 percent of what it recovered in FY 2021.

SCOTUS to Decide Monumental Question Affecting Providers’ FCA Liability

SCOTUS to Decide Monumental Question Affecting Providers’ FCA Liability

by Glenn S. Demby | Apr 17, 2023 | Essential, Legislation-nir, National Lab Reporter

It’s not just billions of dollars on the line, but the very future of whistleblower lawsuits and FCA enforcement.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
FCA Enforcement Activity Is Up but Recovery Dollars Are Down

FCA Enforcement Activity Is Up but Recovery Dollars Are Down

by Glenn S. Demby | Apr 17, 2023 | Enforcement-nir, Essential, National Lab Reporter

The DOJ’s recent report on FCA enforcement statistics for FY 2022 shows that while actions are dramatically up, recoveries are way down.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Court OKs Qui Tam Lawsuit against Lab for Not Following Medicare LCD

Court OKs Qui Tam Lawsuit against Lab for Not Following Medicare LCD

by Glenn S. Demby | Nov 25, 2022 | Essential, False Claims-lca, Lab Compliance Advisor

Could not following MAC guidance constitute evidence that a party knowingly submitted, or caused the submission of, false claims?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
SCOTUS Won’t Weigh in on How Whistleblowers Make Valid FCA Claims

SCOTUS Won’t Weigh in on How Whistleblowers Make Valid FCA Claims

by Glenn S. Demby | Nov 17, 2022 | Enforcement-nir, Essential, National Lab Reporter

The court recently denied the petition to hear a case that would have helped offer clarity on what evidence whistleblowers need to file qui tam lawsuits under the FCA.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com